Anika Therapeutics, Inc. logo ANIK - Anika Therapeutics, Inc.

NEXT EARNINGS: Feb 26, 2026 (in 8 days)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0
Market Cap: 151.71M
Volume: 77,938
Avg Volume: 157,720
52 Week Range: 7.87-18.35
Sector: Healthcare
Industry: Medical - Devices
Beta: 0.43
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 288
IPO Date: 1993-05-03
EPS (TTM): -3.83
P/E Ratio: -4.30
Revenue (TTM): 119.91M
Total Assets: 202.74M
Total Debt: 25.93M
Cash & Equiv: 55.63M
Rev Growth (5Y): 0.9%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -2.8%
Debt/Equity: 0.17

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 119.91M 120.79M 113.83M 147.79M 130.46M 114.61M 105.56M 113.42M 103.38M 93.00M 105.59M 75.08M
Net Income (56.38M) (82.67M) (14.86M) 4.13M (23.98M) 27.19M 18.72M 31.82M 32.55M 30.76M 38.32M 20.57M
EPS -3.83 -5.64 -1.02 0.29 -1.69 1.93 1.30 2.18 2.22 2.06 2.61 1.46
Total Assets 202.74M 270.63M 349.13M 347.54M 365.61M 330.71M 278.99M 282.62M 240.25M 235.75M 194.00M 156.04M
Total Debt 25.93M 27.74M 30.89M 20.95M 22.46M 22.51M N/A N/A N/A N/A N/A N/A
Cash & Equivalents 55.63M 68.74M 86.33M 94.39M 95.82M 157.46M 89.04M 133.26M 104.26M 110.71M 100.16M 63.33M
Operating Cash Flow 5.40M (1.79M) 4.41M 8.40M 13.06M 37.01M 34.92M 40.81M 23.80M 39.06M 39.98M 25.16M
Free Cash Flow (2.33M) (7.21M) (3.08M) 3.25M 11.44M 34.18M 30.26M 31.83M 9.79M 29.84M 38.43M 24.72M
FCF per Share -0.16 -0.49 -0.21 0.23 0.80 2.42 2.10 2.18 0.67 2.00 2.62 1.76
Book Value 153.99M 212.26M 285.56M 287.08M 272.40M 288.38M 263.61M 263.49M 222.77M 210.85M 178.10M 135.63M
Cash & ST Investments 55.63M 68.74M 86.33M 94.39M 98.32M 184.94M 159.01M 157.26M 124.76M 138.46M 106.91M 63.33M
ROC Equity -0.37 -0.39 -0.05 0.01 -0.09 0.09 0.07 0.12 0.15 0.15 0.22 0.15